Oxytocin and Fetal Heart Rate Changes
Purpose
The reported risk of nonreassuring fetal heart trace following neuraxial analgesia is 3-23%. This variability may be due to fluid and oxytocin management prior to and during the initiation of neuraxial analgesia. The study hypothesis is that decreasing the oxytocin infusion rate by 50 % prior to initiation of combined spinal epidural analgesia will cause a reduction in the incidence of adverse fetal heart rate changes.
Conditions
- Fetal Bradycardia Complicating Labor and Delivery
- Fetal Bradycardia During Labor
- Fetal Heart Rate or Rhythm Abnormality Affecting Fetus
Eligibility
- Eligible Ages
- Between 18 Years and 55 Years
- Eligible Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Healthy nulliparous or multiparous women at term (37 > weeks' gestation) - Singleton pregnancy - Request for neuraxial analgesia - Oxytocin used for induction of labor or augmentation of labor per institutional protocols
Exclusion Criteria
- Use of chronic analgesic medications - Prior administration of systemic opioid labor analgesia - Non-vertex presentation - Contraindication to neuraxial analgesia - Category 3 fetal heart rate tracing prior to the initiation of combined spinal epidural analgesia
Study Design
- Phase
- Phase 4
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- Triple (Participant, Investigator, Outcomes Assessor)
- Masking Description
- The labor room nurse will be aware of the patient group assignment and will adjust the dose of the drug based on group assignment. The Investigator, Physician Provider and Outcome Assessor will be blinded.
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
No Intervention Standard Dose Oxytocin |
Patients randomized to the standard dose oxytocin will have their oxytocin infusion maintained at the standard of care protocol prior to placement of a combined spinal epidural for labor analgesia |
|
|
Experimental Half Dose Oxytocin |
Patients randomized to the half dose oxytocin will have their oxytocin infusion reduced by 50 % prior to placement of a combined spinal epidural for labor analgesia. |
|
Recruiting Locations
Iowa City, Iowa 52245
More Details
- NCT ID
- NCT03232918
- Status
- Recruiting
- Sponsor
- Unyime Ituk
Detailed Description
Oxytocin is used in labor and delivery to increase the frequency of contractions and augment uterine contractile strength, thereby establishing a regular pattern of labor. However, the administration of exogenous oxytocin in the presence of an uncoordinated labor pattern confers a risk for an increase in uterine contraction frequency, resulting in inadequate relaxation periods. This leads to an increase in the basal tone of the uterus, which may lead to a tetanic contraction with the risk of decreased uteroplacental blood flow and fetal hypoxemia. Previous studies investigating low- versus high-dose oxytocin for induction or augmentation of labor have had conflicting results on the effect on fetal heart rate abnormalities. One of the limitations of these studies is that the labor analgesia was not standardized. The combination of low-dose combined spinal epidural analgesia and the high/low dose oxytocin have not been evaluated. One of the proposed mechanisms for nonreassuring fetal heart a tracing after initiation of analgesia is that the pain relief from neuraxial analgesia causes a decrease in catecholamine release by the sympathetic nervous system. The subsequent decrease in the circulating epinephrine concentration contributes to an increase in uterine tone, as epinephrine is a potent tocolytic agent. The increased tone, in turn, leads to a decrease in placental blood flow, and eventually fetal bradycardia. The primary outcome of this study is the incidence of non-reassuring fetal heart rate tracings within the first 60 minutes after the placement of combined spinal epidural analgesia